Pigs are the second most important source of Salmonella infection for humans in Europe after poultry (Anonymous 2009) . One way to decrease a risk of Salmonella transmission from pig meat and slaughter products to humans is to decrease the number of Salmonella-positive pigs at slaughter. Piglets can be infected soon after birth when the infected sow or its environment is the infection source (Proux et al. 2001; Boughton et al. 2007 ). The immunity of newborn piglets could be crucial for eliminating this source of infection. Previously, we demonstrated that vaccination of pregnant sows with experimental inactivated Salmonella enterica serovar Typhimurium (S. Typhimurium) vaccine
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Veterinarni Medicina, 61, 2016 (1): 23-27 doi: 10.17221/8679-VETMED induces colostral immunity responsible for the protection of suckling piglets when challenged with a homologous strain (Matiasovic et al. 2013) . Because Salmonella enterica serovar Derby (S. Derby) and S. Typhimurium belong to the same O:4 group (Grimont and Weill 2007) , the aim of the study was to test potential crossprotectivity of S. Typhimurium vaccine to S. Derby challenge.
MATERIAL AND METHODS
The animal care protocol and its use in this experiment were approved by the Branch Commission for Animal Welfare of the Ministry of Agriculture of the Czech Republic (MZE1358). Four sows negative for Salmonella-specific antibodies, tested with Salmotype pig screen ELISA Kit (Labor Diagnostik, Germany) were used in the experiment. Two sows were vaccinated intramuscularly into the neck with 1 ml of inactivated S. Typhimurium vaccine four and two weeks before parturition and developed antibody response to the vaccine. The in-house vaccine was prepared from S. Typhimurium DT104 incubated overnight in BHI medium to 1 × 10 9 CFU per ml, inactivated with 1% formaldehyde and mixed with ISA50V2 adjuvant (Seppic, France) (Matiasovic et al. 2013) . None of the sows shed Salmonella sp. one week before and four days after parturition when checked daily by the ISO 6579: 2002 bacterial culture method.
IgG antibodies were measured using Salmotype pig screen ELISA Kit and IgA antibodies with a homemade ELISA based on S. Typhimurium O-antigens (Matiasovic et al. 2013) . Briefly, Maxisorp plates (Nunc, Denmark) were coated with S. Typhimurium LPS (Sigma-Aldrich, USA). Serum samples were diluted 100 times and jejunal lavage two times in PBS and applied to coated plates. After incubation, the secondary antibody (Goat anti-pig IgA conjugate, Bethyl Laboratories, USA) conjugated with horseradish peroxidase was added. Subsequently, TMB substrate (Test-line, Czech Republic) was applied and the signal was measured at 450 nm on microplate reader Synergy H1 (Biotek, USA).
Four days after birth, suckling piglets of one vaccinated (n = 10) and one serologically negative sow (n = 8) were orally inoculated with 2.4 × 10 7 CFU of S. Typhimurium (STM challenge group) homologous to the vaccine strain (dose volume 2 ml). Similarly, piglets of two other sows (n = 10 in each group) were orally inoculated with 2.6 × 10 7 CFU of S. Derby (SD challenge group) (Matiasovic et al. 2014 ). All animal groups were individually housed in barrier pens. All piglets remained with their mothers until euthanized by exsanguination from the arteria brachialis under deep anaesthesia at 72 h post inoculation, i.e. at the end of the experiment when the Salmonella load within tissues was anticipated to be maximal (Wood and Rose 1992) .
Quantitative bacteriology was performed by plating ten-fold serial dilutions of homogenised organ samples on XLD agar plates. After direct plating, counts of Salmonella were logarithmically transformed. Samples negative for Salmonella according to the aforementioned method, were subjected to the enrichment in semi-solid Rappaport-Vassiliadis medium (Oxoid, Basingstoke, United Kingdom) for qualitative Salmonella determination. Samples positive only after enrichment were taken as a value of one, and a value of zero was assigned to negative samples.
Influence of anti-S. Typhimurium antibodies on S. Typhimurium and S. Derby motility was tested in vitro according to Forbes et al. (2008) . LB agar (0.3 g of agar per 100 ml, Invitrogen, USA) plates without antibodies or containing 100 × or 1000 × diluted heat-inactivated serum from both vaccinated sows were inoculated with 1 µl of overnight culture of S. Typhimurium or S. Derby. The diameter of migrating bacteria was measured in duplicates each hour of 8 h of cultivation. A test was performed four times, twice for serum from each sow. Salmonellaspecific antibody levels in the serum samples of both sows were 86% and 116% of positive control of Salmotype pig screen ELISA Kit.
The significance of differences among groups for in vivo and for in vitro experiments was tested by ANOVA followed by the Bonferroni's Multiple Comparison Test. Differences with P < 0.05 were considered significant.
RESULTS
On Day Two after inoculation, piglets in all groups developed mild diarrhoea. The only clinical difference among groups was a slightly, but significantly higher body temperature at day two after inoculation in piglets from the serologically negative sow (39.8 °C ± 0.3), when compared to their counterparts from the vaccinated sow (39.3 °C ± 0.3) in S. Typhimurium challenge group. Piglets from both vaccinated sows had significantly higher amounts of Salmonella-specific IgG and IgA antibodies in the blood (Table 1 ) than piglets from serologically negative sows. Piglets from the vaccinated sow in the SD challenge group had slightly, but significantly higher amounts of IgG at Day 0 post infection (DPI 0) than piglets from the vaccinated sow in the STM challenge group. The levels of specific IgA in jejunal lavage in piglets of the vaccinated sow in the SD challenge group were significantly higher than in piglets from the serologically negative sow, whereas in the STM challenge group, the difference between piglets from vaccinated and serologically negative sows was not significant.
Piglets from the vaccinated sow in the STM challenge group had a significantly lower Salmonella Typhimurium count in the ileocaecal lymph node, submandibular lymph node, tonsil, ileum wall and ileum content than piglets from the serologically negative sow (Table 2 ). The spleen was not colonised in any animal and the liver was positive only after enrichment in two piglets from the serologically negative sow. This difference was not statistically significant.
Piglets from the vaccinated sow in the SD challenge group had a significantly lower S. Derby count in ileum content than piglets from the serologically negative sow (Table 2) . However, S. Derby counts in the ileocaecal lymph node, submandibular lymph node, tonsil and ileum were not significantly different. The spleen and liver were S. Derby negative in all animals.
DISCUSSION
Although piglets from the vaccinated sow challenged with S. Derby acquired high levels of anti-S. Typhimurium antibodies (even higher than piglets from the vaccinated sow challenged with S. Typhimurium), their protection against S. Derby infection, measured as a significant decrease in Salmonella counts in tissues, was lower than in the S. Typhimurium challenge group. This might have been influenced by overall lower colonisation of organs by S. Derby, but also by differences in protein sequences between S. Derby and S. Typhimurium. Although both serovars have the same structure of O-antigens, the sequence of fliC protein, the major component of the flagellum, shows 78% similarity STM; vacc.; n = 10 0.00 0.00 1.91 ± 0.47* 1.08 ± 0.42* 0.81 ± 0.50* 4.02 ± 0.27* 2.50 ± 0.22* SD = S. Derby challenge, STM = S. Typhimurium challenge, Ab neg. = piglets from the sow negative for Salmonella-specific antibodies, vacc. = piglets from the vaccinated sow, IC = ileocaecal, LN = lymph node, SM = submandibular, n = number of animals in group Data for the sampled tissues are presented as a mean ± SEM of log 10 values of S. Typhimurium or S. Derby CFU/g for each group. Asterisks indicate the significance of differences (P < 0.05) between piglets from vaccinated and serologically negative sow within challenge group only to the first 190 amino acids (aa) from about 500 aa forming the whole protein (STM 495 aa, SD 504 aa) when compared by blastp using default settings (http://blast.ncbi.nlm.nih.gov). In accordance with this finding, the motility test showed that in vitro anti-S. Typhimurium antibodies significantly reduced the motility of S. Typhimurium but not S. Derby (Figure 1 ). In this test, the presence of anti-S. Typhimurium antibodies in LB semi-solid agar significantly reduced motility of S. Typhimurium from 4 h post inoculation. Under the same conditions the motility of S. Derby was not significantly reduced. The motility of both serovars on plates without antibodies was not significantly different. Another important antigenic target for protective antibodies is membrane protein ompD (Gil-Cruz et al. 2009 ), which has 89% similarity between these two serovars. Different epitopes of S. Derby proteins thus may limit the protectivity of antibodies induced by S. Typhimurium vaccine.
In the past, an effort was made to test crossprotectivity of S. Choleraesuis live attenuated vaccine to S. Typhimurium challenge. In a controlled study it was found that live attenuated S. Choleraesuis vaccine did not reduce shedding (Letellier et al. 2000) , but could stimulate local immunity and reduce the presence of S. Typhimurium in the ileum in swine (Letellier et al. 2001) . Some field studies found that live attenuated S. Choleraesuis vaccine reduced seroprevalence and Salmonella isolation in pigs at slaughter (Maes et al. 2001; Schwarz et al. 2011) , whereas others, working with a vaccine based on S. Typhimurium var. Copenhagen, the crossprotectivity did not observed (Farzan and Friendship 2010) .
It has to be taken into account that our data were obtained from a limited number of animals. Nevertheless, it was found that crossprotectivity of antibodies developed after vaccination was reduced between Salmonella Typhimurium and Derby serovars. 
